Among all dopamine receptors, D1R expression is upregulated in breast cancer cells’ population that displays a stem cell phenotype (CD44+ and CD24-) compared to the differentiated breast cancer cells [56,97]. This evidence concerns the gene DRD1 and breast cancer.